Investor Concerns Dragged Gilead Sciences (GILD) in Q2
Ariel Investments, an investment management company, released its “Ariel Global Fund” second-quarter 2023 investor letter. A copy of the same can be downloaded here.
Gilead Sciences Inc. (GILD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AQR Capital Management Cliff Asness | 4,242,374 | $324,668,875 | +21% | 0.69% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 3,980,300 | $306,761,721 | -24% | 0.78% |
| 3. | D E Shaw D. E. Shaw | 2,050,127 | $158,003,288 | +12% | 0.16% |
| 4. | 1,580,400 | $121,801,428 | +9% | 0.02% | |
| 5. | Adage Capital Management Phill Gross And Robert Atchinson | 1,246,588 | $96,074,537 | -24% | 0.2% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.92 | 10,000 | Director | 88,173 | 2015-02-06 | Filing | |
| $43.05 | 10,000 | Director | 69,458 | 2013-02-28 | Filing | |
| $44.00 | 10,000 | Director | 26,097 | 2012-02-22 | Filing | |
| $38.60 | 8,704 | Director | 12,800 | 2010-05-04 | Filing | |
| $38.59 | 4,096 | Director | 4,096 | 2010-05-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $76.99 | 1,501 | Officer | 70,130 | 2023-09-12 | Filing | |
| $80.00 | 5,000 | Officer | 107,587 | 2023-07-20 | Filing | |
| $76.90 | 1,485 | Officer | 29,402 | 2023-06-13 | Filing | |
| $78.99 | 6,126 | Officer | 70,130 | 2023-03-13 | Filing | |
| $79.96 | 12,984 | Officer | 70,130 | 2023-03-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 126,194,179 | $9,725,785,343 | 0.26% | |
| 2. | 113,368,650 | $8,737,321,856 | 0.2% | |
| 3. | 80,929,316 | $6,237,075,034 | 1.19% | |
| 4. | 59,317,162 | $4,571,573,675 | 0.24% | |
| 5. | 57,899,669 | $4,462,323,955 | 1.19% |
News See All
12 Undervalued Wide Moat Stocks To Invest In
The strategy of wide moat investing has gained a lot of traction over the past few years. This strategy is most commonly attributed to Warren Buffett of Berkshire Hathaway. Mr.
13 Best Wide Moat Stocks To Buy According To Hedge Funds
In this piece, we will take a look at the 13 best wide moat stocks to buy according to hedge funds.
Gilead Sciences, Inc. (NASDAQ:GILD) Q2 2023 Earnings Call Transcript
Operator: Hello, everyone. Thank you for attending Gilead Sciences' Second Quarter 2023 Earnings Conference Call. My name is Sarah and I'll be your moderator today.
5 Best Bargain Stocks to Buy in August
In this article, we will be taking a look at the 5 best bargain stocks to buy in August.
Hedge Fund and Insider Trading News: Soroban Capital Partners, Marshall Wace LLP, Citadel LLC, Archegos Capital Management, Bank of America Corporation (BAC), Friedman Industries Inc (FRD), and More
One of the largest IPOs in London this year is already facing pressure from short-sellers, less than a month after it made its debut on the London Stock Exchange.
Medallion Fund Strategy, Returns, and Holdings: Top 5 Stock Picks
In this piece, we will take a look at Medallion's Fund's strategy, returns, and holdings along with the top five stocks.
14 Best NASDAQ Dividend Stocks To Buy
In this article, we discuss 14 best NASDAQ dividend stocks to buy.
10 Martin Shkreli Stock Picks and Their Performance
Martin Shkreli a.k.a. "Pharma Bro" is known for a variety of reasons, many of which are tinged with notoriety.
12 COVID-19 Treatment Stocks Hedge Funds Are Betting On
When most people think about living during a once in a lifetime event, it mostly involves positive scenarios.
Billionaire Hedge Funds
